Discontinued — last reported Q1 '26
Business Segments · Sales
Pharmaceutical — Sales
Merck & Co. Pharmaceutical — Sales decreased by 3.3% to $14.35B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.2%, from $13.64B to $14.35B. Over 4 years (FY 2021 to FY 2025), Pharmaceutical — Sales shows an upward trend with a 8.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026
Rolls up toTotal Revenue
How to read this metric
Growth indicates successful product launches or market share expansion, while decline suggests patent expirations or competitive pressure.
Detailed definition
The total revenue generated from the sale of pharmaceutical products, including prescription drugs and vaccines. It is t...
Peer comparison
The primary benchmark for performance among global pharmaceutical companies.
Metric ID:
mrk_segment_pharmaceutical_segment_salesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.98B | $11.50B | $10.60B | $14.11B | $12.76B | $12.96B | $12.18B | $12.72B | $13.46B | $14.26B | $13.14B | $14.01B | $14.41B | $14.94B | $14.04B | $13.64B | $14.05B | $15.61B | $14.84B | $14.35B |
| QoQ Change | — | +15.2% | -7.8% | +33.0% | -9.6% | +1.6% | -6.0% | +4.5% | +5.8% | +6.0% | -7.9% | +6.6% | +2.9% | +3.7% | -6.0% | -2.9% | +3.0% | +11.1% | -4.9% | -3.3% |
| YoY Change | — | — | — | — | +27.8% | +12.8% | +14.9% | -9.8% | +5.5% | +10.0% | +7.9% | +10.1% | +7.1% | +4.8% | +6.9% | -2.6% | -2.5% | +4.5% | +5.7% | +5.2% |
Range$9.98B – $15.61B
CAGR+7.9%
Avg YoY Growth+6.8%
Median YoY Growth+6.3%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s pharmaceutical — sales?
- Merck & Co. (MRK) reported pharmaceutical — sales of $14.35B in Q1 2026.
- How has Merck & Co.'s pharmaceutical — sales changed year-over-year?
- Merck & Co.'s pharmaceutical — sales increased by 5.2% year-over-year, from $13.64B to $14.35B.
- What is the long-term trend for Merck & Co.'s pharmaceutical — sales?
- Over 4 years (2021 to 2025), Merck & Co.'s pharmaceutical — sales has grown at a 8.0% compound annual growth rate (CAGR), from $42.75B to $58.14B.
- What does pharmaceutical — sales mean?
- Total revenue earned from selling pharmaceutical products.